BIOMAT Database Logo BIOMAT Database Logo

Specificity of antisera to subunit A of blood clotting factor XIII in immunodiffusion. 1975

Y Miura

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D005176 Factor XIII A fibrin-stabilizing plasma enzyme (TRANSGLUTAMINASES) that is activated by THROMBIN and CALCIUM to form FACTOR XIIIA. It is important for stabilizing the formation of the fibrin polymer (clot) which culminates the coagulation cascade. Coagulation Factor XIII,Factor XIII Transamidase,Fibrin Stabilizing Factor,Fibrinase,Laki-Lorand Factor,Blood Coagulation Factor XIII,Factor 13,Factor Thirteen,Laki Lorand Factor,Factor XIII, Coagulation,Stabilizing Factor, Fibrin,Transamidase, Factor XIII,XIII, Coagulation Factor
D005779 Immunodiffusion Technique involving the diffusion of antigen or antibody through a semisolid medium, usually agar or agarose gel, with the result being a precipitin reaction. Gel Diffusion Tests,Diffusion Test, Gel,Diffusion Tests, Gel,Gel Diffusion Test,Immunodiffusions,Test, Gel Diffusion,Tests, Gel Diffusion
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody

Related Publications

Y Miura
[Clotting factor XIII].
January 1981, Wiadomosci lekarskie (Warsaw, Poland : 1960),
Y Miura
[Speeding wound healing by blood clotting factor XIII].
October 1971, Arzneimittel-Forschung,
Y Miura
Factor XIII: congenital deficiency factor XIII, acquired deficiency, factor XIII A-subunit, and factor XIII B-subunit.
February 2014, Archives of pathology & laboratory medicine,
Y Miura
[A means of accelerated determination of blood clotting factor XIII activity].
January 1972, Laboratornoe delo,
Y Miura
Administration of factor XIII B subunit increased plasma factor XIII A subunit levels in factor XIII B subunit knock-out mice.
January 2008, International journal of hematology,
Y Miura
Calcium and the assembly of human blood-clotting factor XIII.
August 1979, Biochemical Society transactions,
Y Miura
Congenital deficiency of clotting factor XIII.
June 1974, The Journal of the American Osteopathic Association,
Y Miura
Intracellular factor XIII: cellular distribution of factor XIII subunit a in humans.
January 1996, Seminars in thrombosis and hemostasis,
Y Miura
Lonomia achelous caterpillar venom (LACV) selectively inactivates blood clotting factor XIII.
July 1997, Thrombosis research,
Y Miura
Enzymes covalently bound on collagen membranes immobilization of blood clotting factor XIII.
January 1988, Advances in experimental medicine and biology,
Copied contents to your clipboard!